CM
CGON icon

Caption Management’s CG Oncology CGON Stock Holding History

Caption Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$78.5M Buy
1,160,000
+557,600
+93% +$31.6M 0.46% 36
2025
Q4 		$25M Buy
+602,400
New +$24.9M 0.17% 131

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Caption Management's CGON Position: Q1 2026 in Review

Caption Management increased its CG Oncology (CGON) stake by 23% in Q1 2026, buying an estimated $4.06M and bringing the position to 378,480 shares worth $25.6M. The position accounts for 0.15% of the portfolio, ranked #138.

Caption Management first reported a position in CGON in Q4 2025 and has held it in 2 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • Caption Management held 378,480 shares of CG Oncology worth $25.6M as of Q1 2026.
  • Caption Management bought 71,634 CG Oncology shares in Q1 2026, an estimated $4.06M.
  • CG Oncology made up 0.15% of Caption Management's portfolio in Q1 2026, its #138 holding.
  • Caption Management first reported a position in CG Oncology in Q4 2025 and has held it in 2 quarters since.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.